431 related articles for article (PubMed ID: 29772686)
1. Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer.
Aldinucci D; Casagrande N
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772686
[TBL] [Abstract][Full Text] [Related]
2. The potential to target CCL5/CCR5 in breast cancer.
Velasco-Velázquez M; Xolalpa W; Pestell RG
Expert Opin Ther Targets; 2014 Nov; 18(11):1265-75. PubMed ID: 25256399
[TBL] [Abstract][Full Text] [Related]
3. Cytokine CCL5 and receptor CCR5 axis in glioblastoma multiforme.
Kranjc MK; Novak M; Pestell RG; Lah TT
Radiol Oncol; 2019 Nov; 53(4):397-406. PubMed ID: 31747383
[TBL] [Abstract][Full Text] [Related]
4. The inflammatory chemokine CCL5 and cancer progression.
Aldinucci D; Colombatti A
Mediators Inflamm; 2014; 2014():292376. PubMed ID: 24523569
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of KLF5 in cancer-associated fibroblasts inhibit gastric cancer cells progression by CCL5/CCR5 axis.
Yang T; Chen M; Yang X; Zhang X; Zhang Z; Sun Y; Xu B; Hua J; He Z; Song Z
Cancer Biol Ther; 2017 Oct; 18(10):806-815. PubMed ID: 28934010
[TBL] [Abstract][Full Text] [Related]
6. CCR5-Mediated Signaling Is Involved in Invasion of Glioblastoma Cells in Its Microenvironment.
Novak M; Koprivnikar Krajnc M; Hrastar B; Breznik B; Majc B; Mlinar M; Rotter A; Porčnik A; Mlakar J; Stare K; Pestell RG; Lah Turnšek T
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545571
[TBL] [Abstract][Full Text] [Related]
7. Cancer cell CCL5 mediates bone marrow independent angiogenesis in breast cancer.
Sax MJ; Gasch C; Athota VR; Freeman R; Rasighaemi P; Westcott DE; Day CJ; Nikolic I; Elsworth B; Wei M; Rogers K; Swarbrick A; Mittal V; Pouliot N; Mellick AS
Oncotarget; 2016 Dec; 7(51):85437-85449. PubMed ID: 27863423
[TBL] [Abstract][Full Text] [Related]
8. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
[TBL] [Abstract][Full Text] [Related]
9.
Battaglin F; Baca Y; Millstein J; Yang Y; Xiu J; Arai H; Wang J; Ou FS; Innocenti F; Mumenthaler SM; Jayachandran P; Kawanishi N; Lenz A; Soni S; Algaze S; Zhang W; Khoukaz T; Roussos Torres E; Seeber A; Abraham JP; Lou E; Philip PA; Weinberg BA; Shields AF; Goldberg RM; Marshall JL; Venook AP; Korn WM; Lenz HJ
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38212126
[TBL] [Abstract][Full Text] [Related]
10. Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy.
Nie Y; Huang H; Guo M; Chen J; Wu W; Li W; Xu X; Lin X; Fu W; Yao Y; Zheng F; Luo ML; Saw PE; Yao H; Song E; Hu H
Clin Cancer Res; 2019 Jul; 25(13):3873-3886. PubMed ID: 30890553
[TBL] [Abstract][Full Text] [Related]
11. Naming the Barriers between Anti-CCR5 Therapy, Breast Cancer and Its Microenvironment.
Brett E; Duscher D; Pagani A; Daigeler A; Kolbenschlag J; Hahn M
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430633
[TBL] [Abstract][Full Text] [Related]
12. The CCL5/CCR5 axis contributes to the perineural invasion of human salivary adenoid cystic carcinoma.
Shen Z; Li T; Chen D; Jia S; Yang X; Liang L; Chai J; Cheng X; Yang X; Sun M
Oncol Rep; 2014 Feb; 31(2):800-6. PubMed ID: 24337063
[TBL] [Abstract][Full Text] [Related]
13. The intricate role of CCL5/CCR5 axis in Alzheimer disease.
Ma W; Liu A; Wu X; Gao L; Chen J; Wu H; Liu M; Fan Y; Peng L; Yang J; Kong J; Li B; Ji Z; Dong Y; Luo S; Song J; Bao F
J Neuropathol Exp Neurol; 2023 Oct; 82(11):894-900. PubMed ID: 37769321
[TBL] [Abstract][Full Text] [Related]
14. CCR5 antagonism by maraviroc inhibits Hodgkin lymphoma microenvironment interactions and xenograft growth.
Casagrande N; Borghese C; Visser L; Mongiat M; Colombatti A; Aldinucci D
Haematologica; 2019 Mar; 104(3):564-575. PubMed ID: 30309853
[TBL] [Abstract][Full Text] [Related]
15. Expression and biological functions of the CCL5-CCR5 axis in oral lichen planus.
Shan J; Li S; Wang C; Liu L; Wang X; Zhu D; Fan Y; Xu J
Exp Dermatol; 2019 Jul; 28(7):816-821. PubMed ID: 31006151
[TBL] [Abstract][Full Text] [Related]
16. The saponin DT-13 inhibits gastric cancer cell migration through down-regulation of CCR5-CCL5 axis.
Lin SS; Fan W; Sun L; Li FF; Zhao RP; Zhang LY; Yu BY; Yuan ST
Chin J Nat Med; 2014 Nov; 12(11):833-40. PubMed ID: 25480514
[TBL] [Abstract][Full Text] [Related]
17. Role of RANTES and its receptor in gastric cancer metastasis.
Cao Z; Xu X; Luo X; Li L; Huang B; Li X; Tao D; Hu J; Gong J
J Huazhong Univ Sci Technolog Med Sci; 2011 Jun; 31(3):342-347. PubMed ID: 21671175
[TBL] [Abstract][Full Text] [Related]
18. Stromal CCL5 Promotes Breast Cancer Progression by Interacting with CCR3 in Tumor Cells.
Yamaguchi M; Takagi K; Narita K; Miki Y; Onodera Y; Miyashita M; Sasano H; Suzuki T
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671956
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression via CCR5.
Nishikawa G; Kawada K; Nakagawa J; Toda K; Ogawa R; Inamoto S; Mizuno R; Itatani Y; Sakai Y
Cell Death Dis; 2019 Mar; 10(4):264. PubMed ID: 30890699
[TBL] [Abstract][Full Text] [Related]
20. Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions.
Aldinucci D; Lorenzon D; Cattaruzza L; Pinto A; Gloghini A; Carbone A; Colombatti A
Int J Cancer; 2008 Feb; 122(4):769-76. PubMed ID: 17935139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
